一个细胞和分子基础的抗素耐药性
Bowen Tan1, Kristina Hedbacker1, Leah Kelly1
1Laboratory of Molecular Genetics, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Cell metabolism
|March 5, 2025
概括
饮食诱导的肥胖会导致小鼠的瘦素抵抗. 抑制POMC神经元中的mTOR逆转了这种抵抗,揭示了肥胖发展的关键机制.
科学领域:
- 神经科学是一个神经科学.
- 代谢过程中的代谢.
- 内分泌学 在内分泌学.
背景情况:
- 小鼠的饮食诱导肥胖 (DIO) 反映了人类的肥胖,其特点是高水平的素和抗素.
- 瘦素耐药的潜在机制,肥胖的一个关键因素,仍然在很大程度上是未知的.
研究的目的:
- 为了研究哺乳动物目标拉巴胺素 (mTOR) 激活在饮食诱导的肥胖小鼠中抗素的发展中的作用.
- 为了确定是否针对mTOR可以恢复瘦素敏感性和影响肥胖.
主要方法:
- 在饮食诱导的肥胖小鼠中,给予莱普和拉巴胺素 (一种mTOR抑制剂).
- 评估身体脂肪,瘦素敏感性和信号通路的变化,特别是涉及POMC神经元.
- 在POMC神经元中对mTOR活动的基因操纵.
主要成果:
- 莱普治疗减少了mTOR激活配体 (白,氨酸),这表明mTOR和莱普信号之间存在联系.
- 在DIO小鼠中,拉帕米辛治疗降低了脂肪质量和提高了瘦素敏感性.
- 特别是在POMC神经元中的mTOR激活被发现是必要的,并且足以引起勒素耐药性.
结论:
- 增加POMC神经元中的mTOR活性是一个关键的致病机制,在饮食诱导的肥胖中驱动瘦素耐药性.
- 在POMC神经元中抑制mTOR可以恢复瘦素敏感性并减少肥胖.
- 这项研究确定了一种新的治疗目标,用于肥胖和抗素的治疗.
更多相关视频
相关概念视频
Obesity
358
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
358
Regulation of Food Intake
174
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
174
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Overview of Lipid Metabolism
925
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
925
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


